Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | APC |
Variant | N1819fs |
Impact List | frameshift |
Protein Effect | unknown |
Gene Variant Descriptions | APC N1819fs results in a change in the amino acid sequence of the Apc protein beginning at aa 1819 of 2843, likely resulting in premature truncation of the functional protein (UniProt.org). N1819fs has been identified in the scientific literature (PMID: 28179481), but has not been biochemically characterized and therefore, its effect on Apc protein function is unknown (PubMed, Aug 2024). |
Associated Drug Resistance | |
Category Variants Paths |
APC mutant APC N1819fs |
Transcript | NM_000038.6 |
gDNA | chr5:g.(112841048_112841049) |
cDNA | c.(5455_5454) |
Protein | p.N1819fs |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_001127510.3 | chr5:g.(112841048_112841049) | c.(5455_5454) | p.N1819fs | RefSeq | GRCh38/hg38 |
NM_001127510 | chr5:g.(112841048_112841049) | c.(5455_5454) | p.N1819fs | RefSeq | GRCh38/hg38 |
NM_000038 | chr5:g.(112841048_112841049) | c.(5455_5454) | p.N1819fs | RefSeq | GRCh38/hg38 |
NM_001354905.2 | chr5:g.(112841528_112841529) | c.(5455_5454) | p.N1819fs | RefSeq | GRCh38/hg38 |
NM_001354905.1 | chr5:g.(112841528_112841529) | c.(5455_5454) | p.N1819fs | RefSeq | GRCh38/hg38 |
NM_001354895.2 | chr5:g.(112841048_112841049) | c.(5455_5454) | p.N1819fs | RefSeq | GRCh38/hg38 |
NM_001407452.1 | chr5:g.(112841078_112841079) | c.(5455_5454) | p.N1819fs | RefSeq | GRCh38/hg38 |
NM_000038.6 | chr5:g.(112841048_112841049) | c.(5455_5454) | p.N1819fs | RefSeq | GRCh38/hg38 |
NM_001407450.1 | chr5:g.(112841048_112841049) | c.(5455_5454) | p.N1819fs | RefSeq | GRCh38/hg38 |
NM_000038.5 | chr5:g.(112841048_112841049) | c.(5455_5454) | p.N1819fs | RefSeq | GRCh38/hg38 |
NM_001354895.1 | chr5:g.(112841048_112841049) | c.(5455_5454) | p.N1819fs | RefSeq | GRCh38/hg38 |
NM_001127510.2 | chr5:g.(112841048_112841049) | c.(5455_5454) | p.N1819fs | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|---|---|---|---|---|---|---|
APC mutant | colorectal cancer | predicted - sensitive | K-756 | Preclinical | Actionable | In a preclinical study, K-756 inhibited Wnt signaling and reduced growth of 2/3 tested APC-mutant colorectal cancer cell lines in culture (PMID: 27196752). | 27196752 |
APC mutant | desmoid tumor | not applicable | N/A | Guideline | Diagnostic | APC mutations aid the diagnosis of desmoid tumor (NCCN.org). | detail... |
APC mutant | colon adenoma | predicted - sensitive | TetMYB | Preclinical | Actionable | In a preclinical study, TetMYB treatment resulted in improved median survival compared to control (356 vs 183 days) in APC-driven mouse models of colon adenoma (Gastroenterology, Volume 154, Issue 6, Supplement 1, May 2018, Pages S-1269). | detail... |
APC mutant | desmoid tumor | predicted - sensitive | Nirogacestat | Phase III | Actionable | In a Phase III trial (DeFi), Ogsiveo (nirogacestat) treatment resulted in improved progression-free survival (HR=0.21, p=0.016) and improved objective response rate (38% (5/13) vs. 13% (2/16)) compared to treatment with placebo in patients with desmoid tumors harboring mutations in APC (J Clin Oncol 42, 2024 (suppl 16; abstr 11558); NCT03785964). | detail... |
APC mutant | medulloblastoma | not applicable | N/A | Guideline | Prognostic | WNT-driven medulloblastomas, characterized by CTNNB1 or APC mutations, are associated with favorable prognosis (NCCN.org). | detail... |
APC mutant | colorectal cancer | no benefit | G-631 | Preclinical - Cell line xenograft | Actionable | In a preclinical study, G-631 inhibited Wnt pathway signaling in colorectal cancer cell line xenograft models harboring an APC mutation, but demonstrated little anti-tumor activity and led to intestinal toxicity (PMID: 26692561). | 26692561 |
APC mutant | small intestine adenocarcinoma | not applicable | N/A | Guideline | Risk Factor | Familial adenomatous polyposis results from germline mutations in the APC gene, and is associated with increased risk of developing small bowel adenocarcinoma (NCCN.org). | detail... |
APC mutant | colorectal cancer | sensitive | JW74 | Preclinical | Actionable | In a preclinical study, JW74 reduced tumor formation and growth in a mouse model of colorectal cancer harboring an APC mutation (PMID: 21199802). | 21199802 |